ABSTRACT Plasma levels of lipids, lipoproteins, and apoproteins in 281 patients undergoing cardiac catheterization were correlated with the incidence and severity of coronary artery disease (CAD) to determine if measurements of apoprotein levels are more predictive of the presence and severity of CAD than the corresponding levels of lipoprotein lipids. In 156 men with CAD among 194 men in the study the only variable other than age that correlated with the severity of CAD, defined by the number of lesions and percent stenosis, was the ratio of apoprotein AI to apoprotein B (r = .1908, p < .03). The ratio of apoprotein AI to apoprotein B was a more accurate predictor of the severity of CAD than was the ratio of the corresponding high-density to low-density lipoprotein levels (coefficients of partial determination of .07 and .035; p < .001 and p < .07, respectively). Multivariate analysis confirmed the independent effect of the ratio of apoprotein AI to apoprotein B on the severity of CAD even after adjustments were made for lipid levels, age, presence of hypertension or diabetes, and therapy with ,8-blockers or diuretics. Among men with total occlusion of a coronary artery apoprotein E and apoprotein B levels were significantly higher than in control subjects with a similar extent of CAD (p < .03). The lipid profiles of the 37 women with CAD were very different from those of the men. In women, only total triglycerides and apoprotein B levels correlated with the severity of disease (r = .3670, p < .03 and r = .3635, p < .04, respectively), as confirmed by multivariate analysis. The results of this study indicate that levels of certain apoproteins may be more accurate predictors of the severity of CAD than are the corresponding levels of lipoprotein lipids, in keeping with the pivotal roles of apoproteins in normal and abnormal lipid metabolism. However, lipids and apoproteins are both weak predictors of lesion severity and cannot be used in the diagnosis of CAD. Circulation 73, No. 5, 978-986, 1986. ABNORMALITIES in plasma levels of lipids have long been recognized as risk factors for coronary artery disease (CAD). In particular, there are direct correlations between the incidence of clinically manifest disease and plasma levels of low-density lipoprotein (LDL) cholesterol and inverse correlations between disease and levels of high-density lipoprotein (HDL) cholesterol.".2 However, most angiographic3 4 and autopsy studies5' 6 have failed to show a correlation be-
ABNORMALITIES in plasma levels of lipids have long been recognized as risk factors for coronary artery disease (CAD). In particular, there are direct correlations between the incidence of clinically manifest disease and plasma levels of low-density lipoprotein (LDL) cholesterol and inverse correlations between disease and levels of high-density lipoprotein (HDL) cholesterol.".2 However, most angiographic3 4 and autopsy studies5' 6 have failed to show a correlation be-tween the severity of CAD and the degree of lipid abnormality, and no single lipid abnormality or combination of abnormalities can adequately discriminate between patients with and without CAD. This may reflect quantitative limitations of angiography, the lack of truly normal vessels as a reference in patients with atherosclerosis, or the lack of focus on physiologically pivotal lipoprotein moieties.
Indeed, it has become increasingly clear that while the lipids in lipoproteins are the transported moieties, the protein moieties of the lipoproteins -the apoproteins -perform the crucial roles of transporting the lipids, and apoproteins can determine the levels of lipoprotein lipids. Therefore, attempts have been made to assess the relationships between plasma apoprotein concentrations and CAD. For example, it has been reported that low levels of apoprotein AI (apoAl), a major constituent of HDL, and high levels of apoprotein B (apoB), a major constituent of LDL, or the ratios CIRCULATION of apoAI/apoB are predictive of the presence of significant CAD.7-'0 Recently a third apoprotein, apoprotein E (apoE), which in normal plasma is about equally divided between very LDL (VLDL) and HDL ,," 12 has been implicated in the pathogenesis of atherosclerosis.'3' 14 The present study was initiated to determine if the absolute levels of plasma apoAl, apoB, or apoE or the distribution of apoE between VLDL and HDLI correlate with the angiographically determined severity of CAD more closely than the more traditionally quantified lipids. The results indicate that apolipoprotein determinations correlate with the severity of disease more significantly than do levels of corresponding lipoprotein lipids. Furthermore, the relationships are different for men and for women. Nevertheless, the relationship of either lipids or apoproteins to severity of coronary disease is of low order, and neither measurement represents an adequate index of severity of CAD. TABLE 2 Absence of CAD was defined as a CAD score of zero (see below). The total study population was therefore 281 (table 1) . It consisted of 87 women with an age range of 46 to 79 years and with a mean age of 60.8 + 0.9(SE) years. The 37 women with CAD were from 46 to 74 years old and the 50 without CAD were 47 to 79 years old. The 194 men had an age range of 27 to 85 years, with a mean of 56.6 + 0.8 years. The age ranges of the 156 men with and the 38 men without CAD were 27 to 76 and 38 to 85 years, respectively. All patients fasted for at least 10 hr before catheterization and were premedicated with hydroxyzine, diazepam, and meperidine. No conventionally required medications were withheld because of this study, but a complete record was kept of all medications received by each patient (table 2) .
Methods
Baseline clinical data obtained before the time of catheterization included age, sex, height, weight, and history with respect to diabetes mellitus, hypertension, or smoking. All patients were questioned regarding past use of either ,8-blockers or diuretics because these medications could have altered lipoprotein levels. 15 Catheterization was performed by either the Sones'6 or the Judkins technique. 17 Multiple views, including angulated views, were obtained of both right and left coronary arteries. Thirty milliliters of blood for lipid analysis was collected into Vacutainer tubes containing EDTA (1 mg/ml blood) at the time of venous access before any heparin was administered. The angiograms were reviewed specifically for this study by one blinded observer without knowledge of the lipid levels. The percentage of stenosis was determined with the aid of calipers and with the use of an apparently normal segment of vessel distal to the lesion as a reference. In all cases the angiographic view showing the most severe stenosis was selected for grading. Lesions of 25% to 50% of luminal diameter were given a score of 1, those of 50% to 75% a score of 2, those of 75% to 90% a score of 3, those of 90% to 94% a score of 4, those of 99% a score of 5, and those causing total obstruction a score of 6. All lesions were scored except those less than 25% of luminal diameter and those distal to a total obstruction, even though they were visualized by retrograde filling of the vessel. A total coronary score reflecting the extent of CAD was determined for each patient by taking the sum of the scores for each lesion. In addition, a prognostic score was determined for each patient according to the method of Gensini. 18 To determine the reproducibility of the score, 30 angiograms were selected at random for blinded reanalysis. The coefficient of variation in coronary score of 12% for the single observer was lower than coefficients of variation reported by others for interobserver variability when more than one observer performed the analyses. 19, 20 Each of the following 17 variables was correlated with the coronary artery score: total triglycerides, total cholesterol, LDL cholesterol, HDL cholesterol,2' apoAI,22 apoAII,23 apoB,24 apoE,25 apoE levels in VLDL (VLDL-apoE), the ratio of apoE in VLDL to total apoE levels (VLDL-apoE/total apoE), the ratios of apoAl/apoAll, HDL/LDL, apoAl/apoB, and age, smoking, and histories of diabetes and hypertension. 
Results
Apoproteins and the severity of coronary atherosclerosis.
Analyses are presented separately for the sexes because of the well-known differences in the distribution of lipoprotein levels in men and women.' The lipid profiles of the 37 women in our study with CAD were very different from those of the men, even though the age distributions were similar (62 + 1.5 years for the women and 59 ± 0.9 for the men). The women with CAD had higher total cholesterol (226 ± 6.5 vs 21 1 ± 2.9 mg/dl, p < .03), LDL cholesterol (158 ± 5.7 vs 142 ± 2.7 mg/dl, p < .001), and HDL cholesterol levels (42 ± 2.0 vs 36 ± 0.69 mg/dl, p < .02) than did the men with CAD. In addition, the relationships between lipid profiles and severity of disease were different for women than for men (table 3; figure 1 ). In contrast to the case for men, in whom the apoAl/apoB ratio was important (univariate analysis r = -. 1908, p < .03; table 3), in women levels of total triglycerides and apoB correlated with severity of disease (r = .3670, p < .03 and r = .3635, p < .04). Next, multiple regression analyses were carried out to identify significant predictors of CAD score (table  4) . Because of the highly significant correlation between age and total coronary score in men (p < .0001), the multiple regression analysis of data from male subjects was adjusted first for the effect of age (table 4, p1 column). Significant age-adjusted effects were found for apoAI/B (p = .006), apoB (p = .0343), VLDLapoE (p = .0428), and VLDL-apoE/total apoE (p = .0346).
Certain apoprotein levels are known to be correlated with some lipoprotein lipids. To identify the importance of the individual apoprotein measurements relative to the related lipids, multiple linear regression was carried out with the six pairs of variables that were most highly correlated with one another (correlation coefficients from .60 to .92). Included were (1) apoB and total cholesterol, (2) apoB and LDL cholesterol, (3) apoAl and HDL cholesterol, (4) VLDL-apoE and total triglycerides, (5) VLDL-apoE/total apoE and total triglycerides, and (6) .03). The apoAl/apoB (0.77 ± 0.02 vs 0.85 ± 0.03) and VLDL-apoE/total apoE ratios (0.25 ± 0.02 vs 0.19 ± 0.02) appeared to differ in the two groups, but not significantly (p < .07). In a similar analysis comparing 13 women with total occlusion of a coronary artery and eight without total occlusion, coronary disease scores were between 8 and 20 and mean scores were 14.0 ± 1.2 and 14.4 ± 1.8 in the two groups. A significant difference was found in levels of total cholesterol (p < 0.05) and a nearly significant difference (p < 0.08) was found in levels of LDL cholesterol, but the small sample size of the two subgroups limited the power of tests for other potentially significant differences.
Apoproteins and the presence or absence of significant lesions. In contrast to the important predictive power of the apolipoproteins in relation to the severity of CAD, apoprotein levels did not increase ability to discriminate between catheterized patients with and without CAD. The characteristics of patients with and without CAD are listed in table 7. The men with CAD were older (p < .0001), had higher total cholesterol (p < .02) and LDL cholesterol levels (p < .02), and also Stepwise logistic regression was used to identify useful predictors of the presence of CAD. The list of potential predictors was narrowed by use of those variables that when used as a single independent variable provided a p value less than .1. Those variables that achieved significance (p < .05) in the bivariate analysis summarized in table 7 were used as well. This procedure added HDL cholesterol/LDL cholesterol and apoB to the list of potential predictors of CAD among men. When all potential predictors were analyzed with multiple logistic regression, the only variables that retained significance were age, total cholesterol, hypertension, and diabetes in men and total triglycerides and LDL cholesterol in women. Thus, none of the apoprotein variables independently enhanced the power of prediction of the presence or absence of significant CAD.
Discussion
The association between blood levels of lipids and CAD is well established. 10-While HDL cholesterol levels are negatively correlated, LDL cholesterol levels are positively correlated with the development of 984 CAD. Recently a great deal of attention has been paid to the role of the apoproteins in the pathogenesis of atherosclerosis because of their pivotal roles in the metabolism of lipoproteins. Also, the potential roles of apoproteins in predicting the presence or the severity of CAD are being evaluated.
Our data suggest that the plasma levels of some apoproteins are more closely related to the severity of CAD than levels of plasma lipids per se (table 4) . Thus, among the men in our study population the variable that correlated most strongly with the severity of disease was the ratio apoAl/apoB (table 3) . Furthermore, for men, both apoB and apoE levels were significantly higher among those with total occlusion than among those with comparably extensive CAD, but without total occlusion of any vessel. The ratio of apoAl/apoB was lower in patients with total occlusion of a coronary artery compared with that in those without total occlusion (table 6). Potentially confounding variables such as taking of medications (table 5) or the presence of diabetes mellitus did not affect the major relationships between apoprotein levels and severity of coronary lesions.
The relationships between apoprotein and lipid levels and CAD scores were different in men and women. Thus, in women only the levels of apoB and triglycerides correlated significantly with the severity of disease, suggesting that different pathogenetic mechanisms may predominate in women. However, the small number of women studied may have limited statistical power to detect potentially important correlations, and a significant relationship of apoAl or the ratio apoAI/apoB to the severity of CAD in women cannot be excluded.
In our analysis apoprotein levels did not add to the power of lipids in distinguishing between the presence and absence of significant CAD. Maciejko et al.l suggested that apoAl levels were a useful marker for the presence of angiographically assessed CAD, but in our study the apoAl levels were not significantly lower in the patients with CAD. One possible explanation for this discrepancy is that the apoAl levels in our patients without CAD (107 ± 3.5) were far lower than the levels found in the normal patients by Maciejko et al.
(147 ± 2.1). This may have been due to differing antibody specificities and/or assay conditions. However, the HDL cholesterol levels of our patients without CAD also did not differ from those of patients with CAD and were lower than those reported for freeliving subjects of similar age, sex, and race. Since apoAl and HDL cholesterol levels were strongly correlated, this suggests that our subjects without CAD were not comparable to free-living control subjects with respect to either HDL cholesterol or apoAl levels. Therefore we cannot conclude that lipid or apoprotein levels do not distinguish asymptomatic free-living people from symptomatic people with angiographically proven significant CAD.
The correlations between levels of apoproteins and the severity of CAD, although statistically significant, were weak. This is not surprising because atherosclerosis is a disease of multifactorial cause. In addition to both qualitative and quantitative changes in lipoprotein levels, hypertension, abnormalities in platelets and circulating catecholamines, stress, and as yet undefined genetic factors have all been implicated.28' 29 Measurements of plasma concentrations of lipids and apoproteins, although useful in identifying some groups at high risk for the development of CAD, do not detect the very important qualitative changes in lipoprotein structures and functions that may be produced at or in the arterial wall. Yet, such qualitative changes may enhance the atherogenic potencies of lipoproteins by altering the interactions between lipoproteins and arterial components (e.g., cells and fibers).
In addition, coronary angiography, although widely accepted as the "gold standard" for diagnosing CAD, provides imperfect measures of the severity of coronary atherosclerosis.33-35 Diffuse CAD resulting in a uniform reduction of luminal diameter throughout a blood vessel may not be appreciated, with consequent underestimation of the severity of disease. Eccentric lesions may not be apparent unless viewed in profile, also leading to underestimation of the severity. In fact, results of most studies suggest that coronary angiograms do underestimate severity of atherosclerosis. Coronary disease scores also may obscure differences in number, location, severity, and complexity of lesions. Accordingly, it is perhaps naive to expect that the measurement of the plasma concentrations of either plasma lipids or apoproteins would be strongly related to the severity of atherosclerotic lesions.
